Literature DB >> 9046260

The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy.

K J Cruickshanks1, R F Hamman, R Klein, D M Nondahl, S M Shetterly.   

Abstract

OBJECTIVES: To determine the prevalence of age-related maculopathy (ARM) in a biethnic population and to determine if there are ethnic and/or geographic differences in the prevalence of ARM.
DESIGN: Prevalence data from 2 population-based studies, the San Luis Valley Diabetes Study (n = 1541, ages 21-74 years) and the Beaver Dam Eye Study (n = 3999, ages 43-74 years), were compared.
SETTING: Southern Colorado and central Wisconsin. MAIN OUTCOME MEASURE: Color stereoscopic fundus photographs were graded for ARM using the Wisconsin Age-related Maculopathy Grading System. Similar questionnaire, laboratory, and clinical data on potential risk factors were available from both studies.
RESULTS: Late-stage ARM was significantly less frequent among Hispanics than non-Hispanic whites (NHW) in Beaver Dam (odds ratio [OR] = 0.07; 95% confidence interval [CI] = 0.01-0.49; Hispanics vs Beaver Dam NHW). The prevalence of any ARM was significantly lower among San Luis Valley NHW (10.4%) than Beaver Dam NHW (14.3%) (OR = 0.67; 95% CI = 0.50-0.91). This prevalence difference was not explained by any of the risk factors examined (smoking, cardiovascular disease, diabetes, alcohol consumption, etc). The 2 NHW groups reported different European heritages.
CONCLUSIONS: Late-stage ARM appeared to be rare among Hispanics but there was no ethnic difference in prevalence of any ARM. The 33% difference in risk among NHW by geographic location was not reduced when controlling for possible risk factors or confounders, suggesting that genetic heritage may be an important determinant of risk for ARM.

Entities:  

Mesh:

Year:  1997        PMID: 9046260     DOI: 10.1001/archopht.1997.01100150244015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  32 in total

1.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

Review 2.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 3.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

4.  Geographic variation in the prevalence of macular disease among elderly medicare beneficiaries in Kansas.

Authors:  Carol Ann Holcomb; Mu-Chuan Lin
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

5.  Mouse models may provide new insight into the relation between cholesterol and age related macular degeneration.

Authors:  J L Duncan
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 6.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

7.  Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.

Authors:  G Silvestri; M A Williams; C McAuley; K Oakes; E Sillery; D C Henderson; S Ferguson; V Silvestri; K A Muldrew
Journal:  Eye (Lond)       Date:  2012-08-17       Impact factor: 3.775

8.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

9.  Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane.

Authors:  Katyanne Dantas Godeiro; Ana Carolina de Arantes Frota; Emilia Antecka; Alexandre Nakao Odashiro; Shawn Maloney; Bruno Fernandes; Miguel Noel Burnier
Journal:  J Carcinog       Date:  2006-08-15

10.  Generational Differences in the 5-Year Incidence of Age-Related Macular Degeneration.

Authors:  Karen J Cruickshanks; David M Nondahl; Lauren J Johnson; Dayna S Dalton; Mary E Fisher; Guan-Hua Huang; Barbara E Klein; Ronald Klein; Carla R Schubert
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.